Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.
paresh_vyas

Prof Paresh Vyas has just been awarded a Grant from Leukaemia and Lymphoma Research  - A first-in-human, first-in-class Phase I dose escalation trial of Humanized Anti-CD47 Monoclonal Antibody Hu5F9-G4 in Acute Myeloid Leukaemia (AML).

Paresh says – “Leukaemia and Lymphoma Research is one of the biggest charitable funders of haematology research in the UK.  They have awarded the MRC Molecular Haematology Unit a grant of £300 000 to conduct a first-in-class first in man clinical trial of a novel immunotherapeutic monoclonal antibody, directed against the cell surface protein CD47, to treat patients with relapsed/refractory Acute Myeloid Leukaemia.  This is an innovative therapeutic that aims to harness the body’s own immune system to fight cancer.  The work is a an exciting collaboration with the Oxford Early Phase Oncology Clinical Trials Unit, Stanford University and the UK AML Clinical Trials Group.“

Similar stories

MRC HIU appoints new Director

MRC HIU RDM

We are pleased to announce that Professor Alison Simmons has been appointed as the new Director of the MRC Human Immunology Unit.

Research unpicks why immune responses decrease with age

MRC MHU

Study reveals what happens to blood cell production during the ageing process, which could help identify new therapeutic targets.

Study uncovers how low blood iron diminishes immune response

MRC HIU NDM RDM

The Drakesmith group finds that low blood serum iron levels can inhibit T-cell and B-cell immune responses to vaccines and infections.

Study finds new human blood disorder

MRC MHU RDM

The Patel Group have discovered a new human disease caused by formaldehyde accumulation in cells

Role-playing computer game helps players understand how vaccines work on a global scale

Centre for Computational Biology MRC HIU RDM

A free game launched today allows players to role-play the deployment of a virtual vaccine to help to halt the global spread of a viral pandemic.